A user's guide to the disease management literature: Recommendations for reporting and assessing program outcomes

American Journal of Managed Care

Volumn 11, Issue 2, 2005, Pages 113-120

  Linden, Ariel ^a,b   Roberts, Nancy ^c  

^a LINDEN CONSULTING GROUP   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c EARLE A CHILES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE MANAGEMENT; MEDICAL RESEARCH; OUTCOMES RESEARCH; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

DISEASE MANAGEMENT; GUIDELINES; HUMANS; JOURNALISM, MEDICAL; OBSERVATION; OUTCOME ASSESSMENT (HEALTH CARE); PEER REVIEW, RESEARCH; PUBLISHING; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 13844269021     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Nurse-driven CHF program cuts hospitalization by 87%. Healthc Demand Dis Manage. 1997;5:78-80.
2. Humana CHF program cuts costs, admissions. Healthc Benchmarks. 1998;5:173-175.
3. Web-based educational effort for CHF patients boost outcomes while cutting costs. Dis Manage Advisor. 2001;7:92-96.
4. Costs drop 37% in Colorado Medicaid asthma DM pilot. Dis Manage News. 2004;9(8):1, 4, 5.
5. Asthma program targets patient and physician compliance; wins first DM excellence award. Healthc Demand Dis Manag. 1998;4(12 suppl 1-4):181-184.
6. 1c in high-risk patients with diabetes. Am J Med Qual. March-April 2003;18:51-58.
7. Ibrahim IA, Beich J, Sidorov J, Gabbay R, Yu L. Measuring outcomes of type 2 diabetes disease management program in an HMO setting. South Med J. 2002;95:78-87.
8. Erdman DM, Cook CB, Greenlund KJ, et al. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes. Diabetes Care. 2002;25:9-15.
9. Whellan DJ, Gaulden L, Gattis WA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001;161:2223-2228.
10. Hershberger RE, Ni H, Nauman DJ, et al. Prospective evaluation of an outpatient heart failure management program. J Card Fail. March 2001;7:64-74.
11. Baillargeon JP, Lepage S, Larrivee L, Roy MA, Landry S, Maheux P. Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: evaluation of a nurse-oriented management approach. Can J Cardiol. 2001;17:169-175.
12. 1c. Am J Manag Care. 2000;6:1217-1226.
13. Jowers JR, Schwartz AL, Tinkelman DG, et al. Disease management program improves asthma outcomes. Am J Manag Care. 2000;6:585-592.
14. Villagra A, Ahmed T. Effectiveness of a disease management program for patients with diabetes. Health Aff. 2004;23:255-266.
15. Johansen LW, Bjorndal A, Flottorp S, Grotting T, Oxman AD. Evaluation of health information in newspapers and brochures. What can we believe? Tidsskr Nor Laegeforen. January 20, 1996;116(2):260-264.
16. Cardium claims big savings, DM observers have doubts. Dis Manage News. 2002;8(3):1, 5, 6.
17. Critics question CO Medicaid's asthma claims. Dis Manage News. 2004;9(9):2, 3, 6.
18. Wilson T, Linden A. Measuring diabetes management [letter]. Health Aff. 2004;23:7, 8.
19. Oxman A, Sackett DL, Guyatt GH. Users' guides to the medical literature, I: how to get started. JAMA. 1993;270:2093-2095.
20. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature, II: how to use an article about therapy or prevention. A. Are the results of the study valid? JAMA. 1993;270:2598-2601.
21. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature, II: how to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? JAMA. 1994;271:59-63.
22. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature, III: how to use an article about a diagnostic test. A. Are the results of the study valid? JAMA. 1994;271:389-391.
23. Jaeschke R, Gordon H, Guyatt G, Sackett DL. Users' guides to the medical literature, III: how to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA. 1994;271:703-707.
24. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature, IV: how to use an article about harm. JAMA. 1994;271:1615-1619.
25. Laupacis A, Wells G, Richardson S, Tugwell P. Users' guides to the medical literature, V: how to use an article about prognosis. JAMA. 1994;272:234-237.
26. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature, VI: how to use an overview. Evidence-Based Medicine Working Group. JAMA. 1994;272:1367-1371.
27. Richardson WS, Detsky AS. Users' guides to the medical literature, VII: how to use a clinical decision analysis. A. Are the results of the study valid? JAMA. 1995;273:1292-1295.
28. Richardson WS, Detsky AS. Users' guides to the medical literature, VII: how to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? JAMA. 1995;273:1610-1613.
29. Hayward RSA, Wilson MC, Tunis SR, Bass EB, Guyatt G. Users' guides to the medical literature, VIII: how to use clinical practice guidelines. A. Are the recommendations valid? JAMA. 1995;274:570-574.
30. Wilson MC, Hayward RSA, Tunis SR, Bass EB, Guyatt G. Users' guides to the medical literature, VIII: how to use clinical practice guidelines. B. What are the recommendations and will they help you in caring for your patients? JAMA. 1995;274:1630-1632.
31. Guyatt GH, Sackett DL, Sinclair JC, et al. Users' guides to the medical literature, IX: a method for grading health care recommendations. JAMA. 1995;274:1800-1804.
32. Naylor CD, Guyatt GH. Users' guides to the medical literature, X: how to use an article reporting variations in the outcomes of health services. Evidence-Based Medicine Working Group. JAMA. 1996;275:554-558.
33. Naylor CD, Guyatt CH. Users' guides to the medical literature, XI: how to use an article about a clinical utilization review. Evidence-Based Medicine Working Croup. JAMA. 1996;275:1435-1439.
34. Guyatt GH, Naylor CD, Juniper E, et al. Users' guides to the medical literature, XII: how to use articles about health-related quality of life. Evidence-Based Medicine Working Croup. JAMA. 1997;277:1232-1237.
35. Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. Users' guides to the medical literature, XIII: how to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Croup. JAMA. 1997;277:1552-1557.
36. O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users' guides to the medical literature, XIII: how to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Croup [published erratum appears in JAMA. 1997;278:1064]. JAMA. 1997;277:1802-1806.
37. O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users' guides to the medical literature, XIII: how to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Croup [published erratum appears in JAMA. 1997;278:1064]. JAMA. 1997;277:1802-1806.
38. Dans AL, Dans LF, Guyatt GH, Richardson S. Users' guides to the medical literature, XIV: how to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Croup. JAMA. 1998;279:545-549.
39. Richardson WS, Wilson MC, Guyatt GH, Cook DJ, Nishikawa J. Users' guides to the medical literature, XV: how to use an article about disease probability for differential diagnosis. JAMA. 1999;281:1214-1219.
40. Guyatt GH, Sinclair J, Cook DJ, Glasziou P. Users' guides to the medical literature, XVI: how to use a treatment recommendation. JAMA. 1999;281:1836-1843.
41. Barratt A, Irwig L, Glasziou P, et al. Users guide to medical literature, XVII: how to use guidelines and recommendations about screening. JAMA. 1999;281:2029-2034.
42. Randolph AG, Haynes RB, Wyatt JC, Cook DJ, Guyatt GH. Users' guide to medical literature, XVIII: how to use an article evaluating the clinical impact of a computer-based clinical decision support system. JAMA. 1999;282:67-74.
43. Bucher HC, Guyatt GH, Cook DJ, Holbrook A, McAlister FA. Users' guides to the medical literature, XIX: applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. JAMA. 1999;282:771-778.
44. McAlister FA, Laupacis A, Wells GA, Sackett DL. Users' guides to the medical literature, XIX: applying clinical trial results. B. Guidelines for determining whether a drug is exerting (more than) a class effect. JAMA. 1999;282:1371-1377.
45. McAlister FA, Straus SE, Guyatt GH, Haynes RB. Users' guides to the medical literature, XX: integrating research evidence with the care of the individual patient. JAMA. 2000;283:2829-2836.
46. Hunt DL, Jaeschke R, McKibbon KA. Users' guides to the medical literature, XXI: using electronic health information resources in evidence-based practice. Evidence-Based Medicine Working Group. JAMA. 2000;283:1875-1879.
47. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature, XXII: how to use articles about clinical decision rules. JAMA. 2000;284:79-84.
48. Giacomini MK, Cook DJ. Users' guides to the medical literature, XXIII: qualitative research in health care. A. Are the results of the study valid? JAMA. 2000;284:357-362.
49. Giacomini MK, Cook DJ. Users' guides to the medical literature, XXIII: qualitative research in health care. B. What are the results and how do they help me care for my patients? JAMA. 2000;284:478-482.
50. Richardson WS, Wilson MC, Williams JW, Moyer VA, Naylor CD. Users' guides to the medical literature, XXIV: how to use an article on the clinical manifestations of disease JAMA. 2000;284:869-875.
51. Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users' guides to the medical literature, XXV: evidence-based medicine: principles for applying the users' guides to patient care. JAMA. 2000;284:1290-1296.
52. Campbell DT, Stanley JC. Experimental and Quasi-experimental Designs for Research. Chicago, III: Rand McNally; 1966.
53. Cook TD, Campbell DT. Quasi-experimentation: Design and Analysis Issues for Field Settings. Chicago, III: Rand McNally College Publishing: 1979.
54. Shadish SR, Cook TD, Campbell DT. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Boston, Mass: Houghton Mifflin; 2002.
55. Wilson T, MacDowell M. Framework for assessing causality in disease management programs: principles. Dis Manag. 2003;6:143-158.
56. Healy B. The Yentl syndrome. N Engl J Med. 1991;325:274-277.
57. Linden A, Adams J, Roberts N. The generalizability of disease management program results: getting from here to there. Manag Care Interface. July 2004:38-45.
58. Schulz KF, Chalmers I, Grimes DA, Altman D. Assessing the quality of randomization from reports of controlled trials published in the obstetrics and gynecology journals. JAMA. 1994;272:125-128.
59. Schulz KF, Chalmers I, Hayes RJ, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
60. Andersen RM. Behavioral Model of Families: Use of Health Services. Chicago, III: Center for Health Administration Studies, University of Chicago; 1968. Research Series No. 25.
61. Aday L, Andersen RM. Equity in access to medical care: realized and potential. Med Care. 1981;19(12 suppl):4-27.
62. Linden A, Adams J, Roberts N. An assessment of the total population approach for evaluating disease management program effectiveness. Dis Manage. 2003;6:93-102.
63. American Healthways and the John Hopkins Consensus Conference. Consensus report: standard outcome metrics and evaluation methodology for disease management programs. Dis Manage. 2003;6:121-138.
64. Linden A, Adams J, Roberts N. Using propensity scores to construct comparable control groups for disease management program evaluation. Dis Manag Health Outcomes. In press.
65. Linden A, Adams J, Roberts N. Using an empirical method for establishing clinical outcome targets in disease management programs. Dis Manage. 2004;7:93-101.
66. Linden A, Roberts N. Disease management interventions: what's in the black box? Dis Manage. 2004;7(4):275-291.
67. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to survival analysis. Dis Manage. 2004;7:180-190.
68. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness adjusting for enrollment (tenure) and seasonably. Res Healthc Financ Manage. 2004;9(1):57-68.
69. Linden A, Adams J, Roberts N. Evaluation Methods in Disease Management: Determining Program Effectiveness. Washington, DC: Disease Management Association of America; October 2003. Position paper.
70. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to time series analysis. Dis Manage. 2003;6:243-255.
71. Jollis JG, Ancukiewicz M, Delong ER, Pryor DB, Muhlbaier LH, Mark DB. Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research. Ann Intern Med. 1993;119:844-850.
72. Hannan EL, Kilburn H Jr, Lindsey ML, Lewis R. Clinical versus administrative data bases for CABG surgery. Does it matter? Med Care. 1992;30:892-907.
73. Bland M. An Introduction to Medical Statistics. 2nd ed. Oxford, UK: Oxford Medical Publications; 1995.
74. Campbell MJ, Machin D. Medical Statistics: A Commonsense Approach. 2nd ed. Chichester, UK: John Wiley and Sons; 1994.
75. Linden A. A Risk-Adjusted Method for Bed-Day Reporting at CareAmerica Health Plans [dissertation]. University of California; Los Angeles; 1997.
76. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to the bootstrap technique. Dis Manage Health Outcomes. In press.
77. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995;310:452-454.